VAERS Explorer
Back to explore

Report #2871106

Received Nov 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (2)

RashSkin burning sensation

Symptom narrative

Small burning spot; rash; This non-serious case was reported by a physician via sales rep and described the occurrence of burning skin in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown deltoid). On an unknown date, 1 week after receiving Shingrix, the patient experienced burning skin (Verbatim: Small burning spot) and rash (Verbatim: rash). The outcome of the burning skin was resolved and the outcome of the rash was not reported. It was unknown if the reporter considered the burning skin and rash to be related to Shingrix. It was unknown if the company considered the burning skin and rash to be related to Shingrix. Additional Information: GSK Receipt Date: 23-OCT-2025 The reporter reported that the rash eventually learned and it was not very big. The batch number was not provided and a request for this information has been made.